364 related articles for article (PubMed ID: 24564507)
1. B-cell hyperactivity in primary Sjögren's syndrome.
Kroese FG; Abdulahad WH; Haacke E; Bos NA; Vissink A; Bootsma H
Expert Rev Clin Immunol; 2014 Apr; 10(4):483-99. PubMed ID: 24564507
[TBL] [Abstract][Full Text] [Related]
2. TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines.
Karlsen M; Jonsson R; Brun JG; Appel S; Hansen T
Scand J Immunol; 2015 Dec; 82(6):523-31. PubMed ID: 26332048
[TBL] [Abstract][Full Text] [Related]
3. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment.
Cornec D; Devauchelle-Pensec V; Tobón GJ; Pers JO; Jousse-Joulin S; Saraux A
J Autoimmun; 2012 Sep; 39(3):161-7. PubMed ID: 22749831
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.
Gong YZ; Nititham J; Taylor K; Miceli-Richard C; Sordet C; Wachsmann D; Bahram S; Georgel P; Criswell LA; Sibilia J; Mariette X; Alsaleh G; Gottenberg JE
J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167
[TBL] [Abstract][Full Text] [Related]
5. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
6. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
[TBL] [Abstract][Full Text] [Related]
7. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.
Hansen A; Lipsky PE; Dörner T
Arthritis Res Ther; 2007; 9(4):218. PubMed ID: 17697366
[TBL] [Abstract][Full Text] [Related]
8. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
[TBL] [Abstract][Full Text] [Related]
10. B-cell populations and sub-populations in Sjögren's syndrome.
Hamza N; Bos NA; Kallenberg CG
Presse Med; 2012 Sep; 41(9 Pt 2):e475-83. PubMed ID: 22841377
[TBL] [Abstract][Full Text] [Related]
11. BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation.
Ding J; Zhang W; Haskett S; Pellerin A; Xu S; Petersen B; Jandreski L; Hamann S; Reynolds TL; Zheng TS; Mingueneau M
Clin Immunol; 2016 Aug; 169():69-79. PubMed ID: 27352977
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
Smith AJ; Gordon TP; Macardle PJ
Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
[TBL] [Abstract][Full Text] [Related]
13. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
14. Immune regulation and B-cell depletion therapy in patients with primary Sjögren's syndrome.
Abdulahad WH; Kroese FG; Vissink A; Bootsma H
J Autoimmun; 2012 Aug; 39(1-2):103-11. PubMed ID: 22341852
[TBL] [Abstract][Full Text] [Related]
15. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
Cornec D; Costa S; Devauchelle-Pensec V; Jousse-Joulin S; Marcorelles P; Berthelot JM; Chiche L; Hachulla E; Hatron PY; Goeb V; Vittecoq O; Saraux A; Pers JO
J Autoimmun; 2016 Feb; 67():102-110. PubMed ID: 26688003
[TBL] [Abstract][Full Text] [Related]
16. The Proteomics of Saliva in Sjögren's Syndrome.
Katsiougiannis S; Wong DT
Rheum Dis Clin North Am; 2016 Aug; 42(3):449-56. PubMed ID: 27431347
[TBL] [Abstract][Full Text] [Related]
17. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
[TBL] [Abstract][Full Text] [Related]
18. The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome.
Hernández-Molina G; Leal-Alegre G; Michel-Peregrina M
Autoimmun Rev; 2011 Jan; 10(3):123-5. PubMed ID: 20833272
[TBL] [Abstract][Full Text] [Related]
19. The T cell in Sjogren's syndrome: force majeure, not spectateur.
Singh N; Cohen PL
J Autoimmun; 2012 Sep; 39(3):229-33. PubMed ID: 22709856
[TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome: an update on epidemiology and current insights on pathophysiology.
Reksten TR; Jonsson MV
Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):1-12. PubMed ID: 24287189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
